Facebook
Twitter
LinkedIn
ForwardFifth Annual Advances in Hematology and Oncology Fall Symposium
The practice of clinical hematology and oncology has been rapidly changing in recent years. Diseases and conditions that previously were extraordinarily difficult to manage have seen new treatment options emerge that have significantly improved clinical outcomes. The Fifth Annual Advances in Hematology and Oncology Fall Symposium will update participants on metastatic colorectal cancer, chronic lymphocytic leukemia, radiation oncology, advanced renal cell carcinoma, nursing session, multiple myeloma, and nonsmall cell lung cancer.
The program is designed to provide practical information on evidence-based practice guidelines and the availability of cancer clinical trials. It is directed at clinicians involved in the treatment of oncology patients including physicians, physician assistants, pharmacists, nurse practitioners.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.5 hours of participation for continuing education for allied health professionals.
AGENDA
6:45-7:45AM Breakfast
7:50-8:00AM Introduction | John Burfeind, MD
8:00-8:40 AM Advances in Regional Therapy for Metastatic
Colorectal Cancer
Harveshp Mogal, MD
8:40-9:20AM New Advances In Chronic Lymphocytic
Leukemia | William Wierda, MD
9:20-9:40AM Break
9:40-10:20AM Breakout Session
1. Radiation Oncology: New Technologies | Meena Bedi, MD
2. Multidisciplinary Management of Advanced Rena Cell Carcinoma
Kathryn Bylow, MD & Peter Langenstroer, MD, MS
3. Enhancing Safety in an Inpatient Oncology Setting
Rebecca Martin, BSN, RN, OCN, BMTCN
10:30-11:10AM CAR-T Cells and the Management of
Multiple Myeloma | Jeff Medin, MD and
Parameswaran Hari, MD
11:10-12:00PM Lunch
12:00-12:40PM The Use of Molecular Targeting in the Treatment Of
Nonsmall Cell Lung Cancer | Joan Schiller, MD
12:40-12:45PM Adjournment | John Burfeind, MD
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses
Learning Objectives
- Summarize current evidence-based practice guidelines for topic area presented.
- List currently available clinical trials that will benefit patients.
- Discuss the most current scientific and clinical research data and apply information to clinical practice.
Hyatt on Main and KI Convention Center
333 Main Street
Green Bay, WI 54301
A block of rooms have been set-aside for meeting attendees on Friday evening October 21st at the Hyatt on Main (Attached to the KI Center), at a special reate of $142 (single or double occupany). Reservations can be made by phone.
Phone Reservations: (888) 421-1442 Group Name: Medical College of Wisconsin
Complimentary parking is available for overnight Hyatt guests. Event attendees should park in the Washington Commons Main Street Parking Ramp, Attached to the KI Convention Center by a connecting skywalk.
Guest Speakers
Joan H. Schiller, MD
Deputy Director for Clinical Investigation
Inova Schar Cancer Institute
William G. Wierda, MD, PhD
Professor and Chief, Section of CLL
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Speakers
Meena Bedi, MD
Assistant Professor
Department of Radiation Oncology
Medical College of Wisconsin
Kathryn Bylow, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Department of Medicine
Medical College of Wisconsin
Peter Langenstroer, MD. MS
Professor of Medicine
Department of Urologic Surgery
Medical College of Wisconsin
Rebecca Martin, BSN, RN, OCN, BMTCN
Staff RN/Educator Inpatient BMT & 4NT
Froedtert and the Medical College of Wisconsin
Jeffrey A. Medin, MD, PhD
MACC Fund Professor
Division of Hematology and Oncology
Department of Pediatrics
Medical College of Wisconsin
Parameswaran Hari, MD, MS
Armand Quick Professor of Hematology
Director of Adult Blood and Marrow Transplant Program
Section Head of Hematologic Malignancies and BMT
Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Harveshp Mogal, MD
Assistant Professor of Surgery
Division of Surgical Oncology
Medical College of Wisconsin
Planning Committee
John Burfeind, MD, Program Director
Thomas Abshire, MD
Jules Blank, MD
David Groteluschen, MD
Parameswaran Hari, MD, MS
Mary Horowitz, MD, MS, FACP
Anthony Jaslowski, MD, FACP
Erica Katuszonek
Wendy Peltier, MD
J. Douglas Rizzo, MD, MS
James Thomas, MD, PhD
Monica Williams
All persons in control of content have NO relevant relationships to disclose with the exception of:
Parameswaran Hari, MD, MS, Celgene, Takeda
Jeffrey Medin, PhD, AvroBio, Plexcera Therapeutics, Rapa Therapeutics
William Wierda, MD, PhD, Sanofi, Genetech/Roche, Celgene, Gilead, GSK/Novartis, Merck, AbbVie, Emergent, Karyopharm, Pharmacyclics, Ascerta, Jansen, Juno Therapeutics, KITE Pharma
Joan Schiller, MD, OncoGenex, Astra Zeneca, Halozyne, Genetech, Bristol Myers, Merck, Xcovery
John Burfeind, MD, Medical Logic, Inc.
In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.
Available Credit
- 3.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.50 Hours of ParticipationHours of Participation credit.